Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Encapsulated on Polyvinylidene Fluoride Membranes (PFM) Promote Functional Recovery from Spinal Cord Injury.
Animals
Cell Differentiation
/ drug effects
Hair Follicle
/ cytology
Membranes, Artificial
Mice, Inbred C57BL
Mice, Nude
Mice, Transgenic
Motor Activity
/ drug effects
Neuroglia
/ drug effects
Neurons
/ drug effects
Pluripotent Stem Cells
/ cytology
Polyvinyls
/ pharmacology
Recovery of Function
/ drug effects
Spinal Cord Injuries
/ pathology
Cardiac muscle cells
Differentiation
Glial cells
Human hair follicle
Nestin
Neurons
Spinal cord injury
Stem cells
Journal
Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
21
10
2018
medline:
25
7
2020
entrez:
21
10
2018
Statut:
ppublish
Résumé
Our previous studies showed that nestin-expressing hair follicle-associated-pluripotent (HAP) stem cells, which reside in the bulge area of the hair follicle, could restore injured nerve and spinal cord and differentiate into cardiac muscle cells. Here we transplanted mouse green fluorescent protein (GFP)-expressing HAP stem-cell colonies enclosed on polyvinylidene fluoride membranes (PFM) into the severed thoracic spinal cord of nude mice. After seven weeks of implantation, we found the differentiation of HAP stem cells into neurons and glial cells. Our results also showed that PFM-captured GFP-expressing HAP stem-cell colonies assisted complete reattachment of the thoracic spinal cord. Furthermore, our quantitative motor function analysis with the Basso Mouse Scale for Locomotion (BMS) score demonstrated a significant improvement in the implanted mice compared to non-implanted mice with a severed spinal cord. Our study also showed that it is easy to obtain HAP stem cells, they do not develop teratomas, and do not loose differentiation ability when cryopreserved. Collectively our results suggest that HAP stem cells could be a better source compared to induced pluripotent stem cells (iPS) or embryonic stem (ES) cells for regenerative medicine, specifically for spinal cord repair.
Identifiants
pubmed: 30341634
doi: 10.1007/s12015-018-9856-3
pii: 10.1007/s12015-018-9856-3
doi:
Substances chimiques
Membranes, Artificial
0
Polyvinyls
0
polyvinylidene fluoride
24937-79-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-66Références
Nat Biotechnol. 2000 Jan;18(1):20-1
pubmed: 10625380
Cell. 2002 Aug 9;110(3):385-97
pubmed: 12176325
Exp Neurol. 2002 Sep;177(1):306-13
pubmed: 12429232
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9958-61
pubmed: 12904579
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13291-5
pubmed: 15331785
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5530-4
pubmed: 15802470
J Neurosci. 2005 May 11;25(19):4694-705
pubmed: 15888645
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14069-74
pubmed: 16172374
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17734-8
pubmed: 16314569
J Neurotrauma. 2006 May;23(5):635-59
pubmed: 16689667
Nature. 2007 Jul 19;448(7151):313-7
pubmed: 17554338
Cell Cycle. 2008 Jun 15;7(12):1865-9
pubmed: 18583926
Science. 2008 Nov 7;322(5903):949-53
pubmed: 18845712
J Cell Biochem. 2009 Aug 1;107(5):1016-20
pubmed: 19507228
Cell Stem Cell. 2009 Sep 4;5(3):237-41
pubmed: 19716359
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12704-9
pubmed: 20615974
Cell Cycle. 2011 Mar 1;10(5):830-9
pubmed: 21330787
Cell Cycle. 2012 Sep 15;11(18):3513-7
pubmed: 22918245
Cell. 2012 Sep 14;150(6):1264-73
pubmed: 22980985
Science. 2013 Nov 1;342(6158):637-40
pubmed: 24179227
Neural Regen Res. 2013 Dec 25;8(36):3365-72
pubmed: 25206658
JAMA Neurol. 2015 Feb;72(2):235-7
pubmed: 25531583
Stem Cell Reports. 2015 Mar 10;4(3):360-73
pubmed: 25684226
Tissue Eng Part C Methods. 2015 Aug;21(8):825-31
pubmed: 25743086
Cell Transplant. 2015;24(4):661-72
pubmed: 25807231
Cell Cycle. 2015;14(14):2362-6
pubmed: 25970547
Cell Cycle. 2016;15(5):760-5
pubmed: 27104748
Cell Cycle. 2016 Oct;15(19):2619-2625
pubmed: 27428074
Methods Mol Biol. 2016;1453:151-9
pubmed: 27431255
Cell Stem Cell. 2016 Oct 6;19(4):544-557
pubmed: 27666009
Cell Cycle. 2017 Jan 2;16(1):95-99
pubmed: 27880068
J Neural Eng. 2017 Apr;14(2):026005
pubmed: 28085005
Int J Mol Sci. 2017 Feb 27;18(3):
pubmed: 28264437
Clin Neuropharmacol. 1987 Jun;10(3):193-204
pubmed: 2842048
Cell Cycle. 2017 Oct 18;16(20):1927-1932
pubmed: 28886268
Nature. 2017 Dec 14;552(7684):S50-S51
pubmed: 29239385
Int J Mol Sci. 2018 Jan 09;19(1):null
pubmed: 29315225
Stem Cells. 2018 May;36(5):696-708
pubmed: 29352743
Nat Med. 2018 May;24(4):484-490
pubmed: 29480894
Sci Transl Med. 2018 May 9;10(440):null
pubmed: 29743351
Cell Stem Cell. 2018 Jun 1;22(6):941-950.e6
pubmed: 29859175
Cell Transplant. 2018 Jul;27(7):1140-1153
pubmed: 29909686
Neural Regen Res. 2018 Jun;13(6):1046-1053
pubmed: 29926832
Int J Mol Sci. 2018 Jul 05;19(7):null
pubmed: 29976859
J Transl Med. 2018 Jul 13;16(1):193
pubmed: 30001730
Biophys J. 2018 Sep 4;115(5):751-753
pubmed: 30119835
FEBS Lett. 1997 May 5;407(3):313-9
pubmed: 9175875
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556